These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5385567)

  • 21. [Relation between sulfobromophthalein Au-198 clearance and scintigraphic aspects in hepatopathies].
    Maduli S; Castagnetti GL
    G Clin Med; 1970 Mar; 51(3):180-256. PubMed ID: 5477744
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sulfobromophthalein test--some problems associated with its procedure and clinical use].
    Fassati P; Fassati M
    Cas Lek Cesk; 1971 Mar; 110(12):271-5. PubMed ID: 5549032
    [No Abstract]   [Full Text] [Related]  

  • 24. [20 min/5 min clearance index of bromosulfophenolphthalein. A simple test of hepatic function].
    Sotto Escobar A
    Rev Esp Enferm Apar Dig; 1986 Feb; 69(2):137-40. PubMed ID: 3704272
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on bromsulphalein retention of the liver].
    Gross W; Beyer E
    Med Klin; 1968 Nov; 63(48):1923-5. PubMed ID: 5710593
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of the relationship between the BSP test and biligraphin excretion in chronic liver diseases].
    Fekete T; Dimitrescu I; Sopon E; Giurgiu A
    Orv Hetil; 1968 Feb; 109(5):242-3. PubMed ID: 5686750
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiences with the BSP double retention test in Tichý's modification].
    Pelikán V; Seidlovà V; Vrublovskỳ P; Sànovà J
    Cesk Gastroenterol Vyz; 1971; 25(5):192-8. PubMed ID: 5162970
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in plasma bromsulphalein clearance induced by ethacrynic acid].
    Pieragnoli E; Divizia G; Porciatti F
    G Clin Med; 1976; 56(2):144-8. PubMed ID: 964522
    [No Abstract]   [Full Text] [Related]  

  • 29. [Heart and liver function test by "clearance" of the BSP].
    Malagelada Benaprés JR; Cavallé Obiols F
    Rev Clin Esp; 1969 Feb; 112(3):301-4. PubMed ID: 5345185
    [No Abstract]   [Full Text] [Related]  

  • 30. [The BSP blood clearance test in the detection of minor hepatic disorders (slightly decompensted minor cholostasis; intestinal bilharziasis)].
    Toulet J; Pichard J; Duchon Y
    Rev Int Hepatol; 1968; 18(4):597-612. PubMed ID: 5688215
    [No Abstract]   [Full Text] [Related]  

  • 31. [Disorders of liver function in endemic nephropathy].
    Milev B
    Z Gesamte Inn Med; 1972 Jul; 27(14):601-5. PubMed ID: 5082874
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical value of liver function appraisal by means of 131-I-rose bengal. 3. Comparison of the results of 131-I-rose bengal test and BSP test.
    Dobrzański Z; Toth Z
    Pol Med J; 1970; 9(3):599-603. PubMed ID: 5460555
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bromsulphalein test in the diagnosis of liver diseases].
    Alekseev VF
    Ter Arkh; 1968 Jul; 40(7):30-3. PubMed ID: 5739330
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatic clearance tests].
    Meeroff JC
    Rev Esp Enferm Apar Dig; 1971 May; 34(4):375-94. PubMed ID: 5565264
    [No Abstract]   [Full Text] [Related]  

  • 35. Indocyanine Green test and its development.
    Namihisa T
    Tokai J Exp Clin Med; 1982 Jul; 7(4):419-23. PubMed ID: 7179313
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative studies on the value of wofaverdin and bromsulfophtalein in childhood].
    Gudowski G; Gmyrek D; Weiland R; Zoellner K
    Dtsch Gesundheitsw; 1967 Sep; 22(35):1656-60. PubMed ID: 5614052
    [No Abstract]   [Full Text] [Related]  

  • 37. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The sulfobromophthalein test: clinical results with a new method of interpretation].
    Barbi G; Sardini D; Tallone G
    Minerva Med; 1968 May; 59(37):2210-3. PubMed ID: 5649326
    [No Abstract]   [Full Text] [Related]  

  • 39. [Function tests in the study of liver disease in children].
    Nemeth A; Strandvik B
    Lakartidningen; 1981 Oct; 78(41):3590-2. PubMed ID: 7321702
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nuclear drugs in hepatological diagnosis. Use of I-131-bromsulphalein].
    Herzmann H; Schmidt E; Schneider G; Schimmelpfennig W; Strangfeld D; Gorka H
    Radiobiol Radiother (Berl); 1970; 11(5):519-26. PubMed ID: 5509220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.